Open-Source Pharmaceuticals?
Much attention has been focused on the pharmaceutical industry’s slowness to develop new drugs and lack of productivity. But the real problem is that pharmaceutical companies cannot sustain their R&D departments, suggesting that they should look to other industries, such as computer software, for examples of pre-competitive collaboration.
https://prosyn.org/INJhkBB
LONDON – Much attention has been focused in recent years on the pharmaceutical industry’s slowness to develop new drugs and lack of productivity. But this crisis of innovation is also affecting the biotechnology firms upon which the large pharmaceutical companies now rely as the pipeline for developing new drugs.